San Jose, CA, United States of America

Faye Loan Du

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Syntis Bio, Inc.. Active years: 2025.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 8.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Faye Loan Du: Innovator in Engineered Leucine Decarboxylases

Introduction

Faye Loan Du is a notable inventor based in San Jose, California. He has made significant contributions to the field of biochemistry through his innovative work on engineered leucine decarboxylases. His research focuses on enhancing the functionality of these enzymes for various applications.

Latest Patents

Faye Loan Du holds a patent for engineered leucine decarboxylase (LDC) polypeptides and their compositions. This invention provides polynucleotides that encode the engineered LDC polypeptides. The engineered LDC polypeptides are optimized to enhance catalytic activity, reduce sensitivity to proteolysis, and increase tolerance to low pH environments. Additionally, these polypeptides are designed to improve storage stability. The invention also outlines methods for utilizing these compositions for therapeutic and industrial purposes.

Career Highlights

Faye Loan Du is currently associated with Syntis Bio, Inc., where he continues to advance his research in biochemistry. His work has the potential to impact various industries by providing innovative solutions through engineered enzymes.

Collaborations

Faye collaborates with talented individuals such as Joyce Liu and Leann Quertinmont Teadt, who contribute to his research endeavors.

Conclusion

Faye Loan Du's innovative work in engineered leucine decarboxylases showcases his commitment to advancing biochemistry. His contributions have the potential to lead to significant advancements in therapeutic and industrial applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…